HEADER APOPTOSIS 02-AUG-20 7JMT TITLE CRYSTAL STRUCTURE OF SCHISTOSOME BCL-2 BOUND TO ABT-737 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BCL-2 PROTEIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SCHISTOSOMA JAPONICUM; SOURCE 3 ORGANISM_COMMON: BLOOD FLUKE; SOURCE 4 ORGANISM_TAXID: 6182; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR N.A.SMITH,B.J.SMITH,E.F.LEE,P.M.COLMAN,W.D.FAIRLIE REVDAT 3 18-OCT-23 7JMT 1 REMARK REVDAT 2 26-MAY-21 7JMT 1 JRNL REVDAT 1 17-FEB-21 7JMT 0 JRNL AUTH W.NGUYEN,E.F.LEE,M.EVANGELISTA,M.LEE,T.J.HARRIS,P.M.COLMAN, JRNL AUTH 2 N.A.SMITH,L.B.WILLIAMS,K.E.JARMAN,K.N.LOWES,C.HAEBERLI, JRNL AUTH 3 J.KEISER,B.J.SMITH,W.D.FAIRLIE,B.E.SLEEBS JRNL TITL OPTIMIZATION OF BENZOTHIAZOLE AND THIAZOLE HYDRAZONES AS JRNL TITL 2 INHIBITORS OF SCHISTOSOME BCL-2. JRNL REF ACS INFECT DIS. V. 7 1143 2021 JRNL REFN ESSN 2373-8227 JRNL PMID 33523649 JRNL DOI 10.1021/ACSINFECDIS.0C00700 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.1_3865 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 86.47 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 30791 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1547 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 86.4700 - 6.1200 0.99 2776 122 0.2168 0.2288 REMARK 3 2 6.1100 - 4.8500 0.99 2655 170 0.2160 0.2094 REMARK 3 3 4.8500 - 4.2400 0.99 2711 110 0.1799 0.1889 REMARK 3 4 4.2400 - 3.8500 0.99 2699 110 0.1941 0.2415 REMARK 3 5 3.8500 - 3.5800 0.99 2583 196 0.2242 0.2410 REMARK 3 6 3.5800 - 3.3700 0.99 2629 178 0.2376 0.2812 REMARK 3 7 3.3700 - 3.2000 0.99 2631 141 0.2750 0.2780 REMARK 3 8 3.2000 - 3.0600 0.99 2650 131 0.2949 0.3450 REMARK 3 9 3.0600 - 2.9400 0.99 2641 132 0.3358 0.3904 REMARK 3 10 2.9400 - 2.8400 0.99 2651 112 0.3381 0.3334 REMARK 3 11 2.8400 - 2.7500 0.98 2618 145 0.3739 0.4103 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.513 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.527 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 78.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 7959 REMARK 3 ANGLE : 1.958 10806 REMARK 3 CHIRALITY : 0.085 1222 REMARK 3 PLANARITY : 0.008 1357 REMARK 3 DIHEDRAL : 21.230 2784 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JMT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-AUG-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30852 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 88.430 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3QBR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SBCL-2:1, 1.6M DIPOTASSIUM HYDROGEN REMARK 280 PHOSPHATE, 0.4M SODIUM DIHYDROGEN PHOSPHATE, 0.2M NACL, 0.1M REMARK 280 IMIDAZOLE, PH8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.89450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ASN A 3 REMARK 465 GLN A 68 REMARK 465 THR A 69 REMARK 465 HIS A 70 REMARK 465 GLU A 71 REMARK 465 ILE A 72 REMARK 465 GLN A 170 REMARK 465 PHE A 171 REMARK 465 VAL A 172 REMARK 465 ASN A 173 REMARK 465 ASP A 174 REMARK 465 GLY A 175 REMARK 465 GLN A 176 REMARK 465 GLU A 177 REMARK 465 LEU A 178 REMARK 465 ILE A 179 REMARK 465 TRP A 180 REMARK 465 LYS A 181 REMARK 465 THR A 182 REMARK 465 LEU A 183 REMARK 465 ARG A 184 REMARK 465 ASN A 185 REMARK 465 VAL A 186 REMARK 465 GLY A 187 REMARK 465 GLY A 188 REMARK 465 LEU A 189 REMARK 465 ALA A 190 REMARK 465 THR A 191 REMARK 465 GLY A 192 REMARK 465 ALA A 193 REMARK 465 VAL A 194 REMARK 465 GLY A 195 REMARK 465 ALA A 196 REMARK 465 LEU A 197 REMARK 465 GLY A 198 REMARK 465 LEU A 199 REMARK 465 ALA A 200 REMARK 465 ALA A 201 REMARK 465 LEU A 202 REMARK 465 VAL A 203 REMARK 465 GLY A 204 REMARK 465 TYR A 205 REMARK 465 ILE A 206 REMARK 465 ALA A 207 REMARK 465 ASN A 208 REMARK 465 LYS A 209 REMARK 465 ILE A 210 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 ASN B 3 REMARK 465 GLN B 68 REMARK 465 THR B 69 REMARK 465 HIS B 70 REMARK 465 GLU B 71 REMARK 465 ILE B 72 REMARK 465 GLU B 73 REMARK 465 PRO B 74 REMARK 465 VAL B 75 REMARK 465 ALA B 76 REMARK 465 GLN B 77 REMARK 465 GLN B 170 REMARK 465 PHE B 171 REMARK 465 VAL B 172 REMARK 465 ASN B 173 REMARK 465 ASP B 174 REMARK 465 GLY B 175 REMARK 465 GLN B 176 REMARK 465 GLU B 177 REMARK 465 LEU B 178 REMARK 465 ILE B 179 REMARK 465 TRP B 180 REMARK 465 LYS B 181 REMARK 465 THR B 182 REMARK 465 LEU B 183 REMARK 465 ARG B 184 REMARK 465 ASN B 185 REMARK 465 VAL B 186 REMARK 465 GLY B 187 REMARK 465 GLY B 188 REMARK 465 LEU B 189 REMARK 465 ALA B 190 REMARK 465 THR B 191 REMARK 465 GLY B 192 REMARK 465 ALA B 193 REMARK 465 VAL B 194 REMARK 465 GLY B 195 REMARK 465 ALA B 196 REMARK 465 LEU B 197 REMARK 465 GLY B 198 REMARK 465 LEU B 199 REMARK 465 ALA B 200 REMARK 465 ALA B 201 REMARK 465 LEU B 202 REMARK 465 VAL B 203 REMARK 465 GLY B 204 REMARK 465 TYR B 205 REMARK 465 ILE B 206 REMARK 465 ALA B 207 REMARK 465 ASN B 208 REMARK 465 LYS B 209 REMARK 465 ILE B 210 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 ASN C 3 REMARK 465 THR C 4 REMARK 465 GLN C 170 REMARK 465 PHE C 171 REMARK 465 VAL C 172 REMARK 465 ASN C 173 REMARK 465 ASP C 174 REMARK 465 GLY C 175 REMARK 465 GLN C 176 REMARK 465 GLU C 177 REMARK 465 LEU C 178 REMARK 465 ILE C 179 REMARK 465 TRP C 180 REMARK 465 LYS C 181 REMARK 465 THR C 182 REMARK 465 LEU C 183 REMARK 465 ARG C 184 REMARK 465 ASN C 185 REMARK 465 VAL C 186 REMARK 465 GLY C 187 REMARK 465 GLY C 188 REMARK 465 LEU C 189 REMARK 465 ALA C 190 REMARK 465 THR C 191 REMARK 465 GLY C 192 REMARK 465 ALA C 193 REMARK 465 VAL C 194 REMARK 465 GLY C 195 REMARK 465 ALA C 196 REMARK 465 LEU C 197 REMARK 465 GLY C 198 REMARK 465 LEU C 199 REMARK 465 ALA C 200 REMARK 465 ALA C 201 REMARK 465 LEU C 202 REMARK 465 VAL C 203 REMARK 465 GLY C 204 REMARK 465 TYR C 205 REMARK 465 ILE C 206 REMARK 465 ALA C 207 REMARK 465 ASN C 208 REMARK 465 LYS C 209 REMARK 465 ILE C 210 REMARK 465 MET D 1 REMARK 465 SER D 2 REMARK 465 ASN D 3 REMARK 465 THR D 4 REMARK 465 THR D 69 REMARK 465 HIS D 70 REMARK 465 GLU D 71 REMARK 465 ILE D 72 REMARK 465 GLU D 73 REMARK 465 PRO D 74 REMARK 465 VAL D 75 REMARK 465 ALA D 76 REMARK 465 GLN D 77 REMARK 465 GLN D 170 REMARK 465 PHE D 171 REMARK 465 VAL D 172 REMARK 465 ASN D 173 REMARK 465 ASP D 174 REMARK 465 GLY D 175 REMARK 465 GLN D 176 REMARK 465 GLU D 177 REMARK 465 LEU D 178 REMARK 465 ILE D 179 REMARK 465 TRP D 180 REMARK 465 LYS D 181 REMARK 465 THR D 182 REMARK 465 LEU D 183 REMARK 465 ARG D 184 REMARK 465 ASN D 185 REMARK 465 VAL D 186 REMARK 465 GLY D 187 REMARK 465 GLY D 188 REMARK 465 LEU D 189 REMARK 465 ALA D 190 REMARK 465 THR D 191 REMARK 465 GLY D 192 REMARK 465 ALA D 193 REMARK 465 VAL D 194 REMARK 465 GLY D 195 REMARK 465 ALA D 196 REMARK 465 LEU D 197 REMARK 465 GLY D 198 REMARK 465 LEU D 199 REMARK 465 ALA D 200 REMARK 465 ALA D 201 REMARK 465 LEU D 202 REMARK 465 VAL D 203 REMARK 465 GLY D 204 REMARK 465 TYR D 205 REMARK 465 ILE D 206 REMARK 465 ALA D 207 REMARK 465 ASN D 208 REMARK 465 LYS D 209 REMARK 465 ILE D 210 REMARK 465 MET E 1 REMARK 465 SER E 2 REMARK 465 ASN E 3 REMARK 465 THR E 4 REMARK 465 GLN E 68 REMARK 465 THR E 69 REMARK 465 HIS E 70 REMARK 465 GLU E 71 REMARK 465 ILE E 72 REMARK 465 GLY E 80 REMARK 465 ILE E 81 REMARK 465 ASP E 82 REMARK 465 SER E 83 REMARK 465 GLN E 170 REMARK 465 PHE E 171 REMARK 465 VAL E 172 REMARK 465 ASN E 173 REMARK 465 ASP E 174 REMARK 465 GLY E 175 REMARK 465 GLN E 176 REMARK 465 GLU E 177 REMARK 465 LEU E 178 REMARK 465 ILE E 179 REMARK 465 TRP E 180 REMARK 465 LYS E 181 REMARK 465 THR E 182 REMARK 465 LEU E 183 REMARK 465 ARG E 184 REMARK 465 ASN E 185 REMARK 465 VAL E 186 REMARK 465 GLY E 187 REMARK 465 GLY E 188 REMARK 465 LEU E 189 REMARK 465 ALA E 190 REMARK 465 THR E 191 REMARK 465 GLY E 192 REMARK 465 ALA E 193 REMARK 465 VAL E 194 REMARK 465 GLY E 195 REMARK 465 ALA E 196 REMARK 465 LEU E 197 REMARK 465 GLY E 198 REMARK 465 LEU E 199 REMARK 465 ALA E 200 REMARK 465 ALA E 201 REMARK 465 LEU E 202 REMARK 465 VAL E 203 REMARK 465 GLY E 204 REMARK 465 TYR E 205 REMARK 465 ILE E 206 REMARK 465 ALA E 207 REMARK 465 ASN E 208 REMARK 465 LYS E 209 REMARK 465 ILE E 210 REMARK 465 MET F 1 REMARK 465 SER F 2 REMARK 465 ASN F 3 REMARK 465 GLN F 68 REMARK 465 THR F 69 REMARK 465 HIS F 70 REMARK 465 GLU F 71 REMARK 465 ILE F 72 REMARK 465 GLN F 170 REMARK 465 PHE F 171 REMARK 465 VAL F 172 REMARK 465 ASN F 173 REMARK 465 ASP F 174 REMARK 465 GLY F 175 REMARK 465 GLN F 176 REMARK 465 GLU F 177 REMARK 465 LEU F 178 REMARK 465 ILE F 179 REMARK 465 TRP F 180 REMARK 465 LYS F 181 REMARK 465 THR F 182 REMARK 465 LEU F 183 REMARK 465 ARG F 184 REMARK 465 ASN F 185 REMARK 465 VAL F 186 REMARK 465 GLY F 187 REMARK 465 GLY F 188 REMARK 465 LEU F 189 REMARK 465 ALA F 190 REMARK 465 THR F 191 REMARK 465 GLY F 192 REMARK 465 ALA F 193 REMARK 465 VAL F 194 REMARK 465 GLY F 195 REMARK 465 ALA F 196 REMARK 465 LEU F 197 REMARK 465 GLY F 198 REMARK 465 LEU F 199 REMARK 465 ALA F 200 REMARK 465 ALA F 201 REMARK 465 LEU F 202 REMARK 465 VAL F 203 REMARK 465 GLY F 204 REMARK 465 TYR F 205 REMARK 465 ILE F 206 REMARK 465 ALA F 207 REMARK 465 ASN F 208 REMARK 465 LYS F 209 REMARK 465 ILE F 210 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 25 CG CD CE NZ REMARK 470 ASP A 27 CG OD1 OD2 REMARK 470 THR A 32 OG1 CG2 REMARK 470 ASP A 33 CG OD1 OD2 REMARK 470 VAL A 75 CG1 CG2 REMARK 470 GLN A 77 CG CD OE1 NE2 REMARK 470 SER A 78 OG REMARK 470 THR B 4 OG1 CG2 REMARK 470 LYS B 25 CG CD CE NZ REMARK 470 ASP B 27 CG OD1 OD2 REMARK 470 THR B 28 OG1 CG2 REMARK 470 THR B 32 OG1 CG2 REMARK 470 LEU B 34 CG CD1 CD2 REMARK 470 ARG B 65 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 81 CG1 CG2 CD1 REMARK 470 LYS B 85 CG CD CE NZ REMARK 470 LYS B 89 CG CD CE NZ REMARK 470 GLU B 105 CG CD OE1 OE2 REMARK 470 ARG B 111 CG CD NE CZ NH1 NH2 REMARK 470 HIS B 129 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 136 CG CD OE1 NE2 REMARK 470 ARG B 169 CG CD NE CZ NH1 NH2 REMARK 470 THR C 32 OG1 CG2 REMARK 470 ASP C 33 CG OD1 OD2 REMARK 470 ARG C 65 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 68 CG CD OE1 NE2 REMARK 470 LYS C 106 CG CD CE NZ REMARK 470 GLU C 165 CG CD OE1 OE2 REMARK 470 LYS D 25 CG CD CE NZ REMARK 470 ASP D 27 CG OD1 OD2 REMARK 470 THR D 28 OG1 CG2 REMARK 470 THR D 32 OG1 CG2 REMARK 470 ARG D 65 CG CD NE CZ NH1 NH2 REMARK 470 GLN D 68 CG CD OE1 NE2 REMARK 470 ILE D 81 CG1 CG2 CD1 REMARK 470 LYS D 85 CG CD CE NZ REMARK 470 ARG D 125 CG CD NE CZ NH1 NH2 REMARK 470 ASP E 27 CG OD1 OD2 REMARK 470 THR E 28 OG1 CG2 REMARK 470 THR E 32 OG1 CG2 REMARK 470 ASP E 33 CG OD1 OD2 REMARK 470 ASN E 37 CG OD1 ND2 REMARK 470 GLN E 77 CG CD OE1 NE2 REMARK 470 LEU E 79 CG CD1 CD2 REMARK 470 LYS E 85 CG CD CE NZ REMARK 470 ARG E 125 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 128 CG CD CE NZ REMARK 470 GLU E 165 CG CD OE1 OE2 REMARK 470 ARG E 169 CG CD NE CZ NH1 NH2 REMARK 470 THR F 28 OG1 CG2 REMARK 470 THR F 32 OG1 CG2 REMARK 470 ASN F 37 CG OD1 ND2 REMARK 470 GLU F 73 CG CD OE1 OE2 REMARK 470 VAL F 75 CG1 CG2 REMARK 470 LEU F 79 CG CD1 CD2 REMARK 470 LYS F 85 CG CD CE NZ REMARK 470 LYS F 106 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O GLY C 168 O GLY F 130 2545 1.69 REMARK 500 OG SER A 17 OD1 ASN D 152 1454 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 131 58.28 -90.01 REMARK 500 LYS B 149 -50.91 -123.58 REMARK 500 PRO C 86 154.68 -45.90 REMARK 500 HIS E 131 54.58 -90.94 REMARK 500 PHE F 104 35.16 -94.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N3C A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N3C B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N3C C 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N3C D 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N3C E 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N3C F 1001 DBREF 7JMT A 1 210 UNP Q5BWX6 Q5BWX6_SCHJA 21 230 DBREF 7JMT B 1 210 UNP Q5BWX6 Q5BWX6_SCHJA 21 230 DBREF 7JMT C 1 210 UNP Q5BWX6 Q5BWX6_SCHJA 21 230 DBREF 7JMT D 1 210 UNP Q5BWX6 Q5BWX6_SCHJA 21 230 DBREF 7JMT E 1 210 UNP Q5BWX6 Q5BWX6_SCHJA 21 230 DBREF 7JMT F 1 210 UNP Q5BWX6 Q5BWX6_SCHJA 21 230 SEQRES 1 A 210 MET SER ASN THR ALA ASP PHE ARG LEU GLN THR SER THR SEQRES 2 A 210 LEU CYS HIS SER PHE LEU LEU ALA SER ALA ASN LYS GLN SEQRES 3 A 210 ASP THR ASP TYR LEU THR ASP LEU LEU ASP ASN THR ASN SEQRES 4 A 210 ILE ASP LEU THR CYS VAL PRO ASN GLY GLN GLU ILE ILE SEQRES 5 A 210 HIS SER LEU LEU GLN LEU VAL GLY ASP PHE ASN GLN ARG SEQRES 6 A 210 PHE SER GLN THR HIS GLU ILE GLU PRO VAL ALA GLN SER SEQRES 7 A 210 LEU GLY ILE ASP SER ASP LYS PRO VAL ASP LYS THR ALA SEQRES 8 A 210 LEU GLU ILE PHE TYR LEU GLU ILE LEU ASN GLY LEU PHE SEQRES 9 A 210 GLU LYS LEU ASN TRP GLY ARG ILE VAL ALA MET PHE ALA SEQRES 10 A 210 PHE LEU ARG ILE LEU VAL LEU ARG LEU SER LYS HIS GLY SEQRES 11 A 210 HIS SER ASP ALA ILE GLN MET LEU ILE LYS THR THR SER SEQRES 12 A 210 GLN TYR SER ASP GLU LYS LEU LYS ASN TRP ILE ASN LEU SEQRES 13 A 210 HIS ASP GLY TRP SER GLY LEU ILE GLU PHE SER GLY ARG SEQRES 14 A 210 GLN PHE VAL ASN ASP GLY GLN GLU LEU ILE TRP LYS THR SEQRES 15 A 210 LEU ARG ASN VAL GLY GLY LEU ALA THR GLY ALA VAL GLY SEQRES 16 A 210 ALA LEU GLY LEU ALA ALA LEU VAL GLY TYR ILE ALA ASN SEQRES 17 A 210 LYS ILE SEQRES 1 B 210 MET SER ASN THR ALA ASP PHE ARG LEU GLN THR SER THR SEQRES 2 B 210 LEU CYS HIS SER PHE LEU LEU ALA SER ALA ASN LYS GLN SEQRES 3 B 210 ASP THR ASP TYR LEU THR ASP LEU LEU ASP ASN THR ASN SEQRES 4 B 210 ILE ASP LEU THR CYS VAL PRO ASN GLY GLN GLU ILE ILE SEQRES 5 B 210 HIS SER LEU LEU GLN LEU VAL GLY ASP PHE ASN GLN ARG SEQRES 6 B 210 PHE SER GLN THR HIS GLU ILE GLU PRO VAL ALA GLN SER SEQRES 7 B 210 LEU GLY ILE ASP SER ASP LYS PRO VAL ASP LYS THR ALA SEQRES 8 B 210 LEU GLU ILE PHE TYR LEU GLU ILE LEU ASN GLY LEU PHE SEQRES 9 B 210 GLU LYS LEU ASN TRP GLY ARG ILE VAL ALA MET PHE ALA SEQRES 10 B 210 PHE LEU ARG ILE LEU VAL LEU ARG LEU SER LYS HIS GLY SEQRES 11 B 210 HIS SER ASP ALA ILE GLN MET LEU ILE LYS THR THR SER SEQRES 12 B 210 GLN TYR SER ASP GLU LYS LEU LYS ASN TRP ILE ASN LEU SEQRES 13 B 210 HIS ASP GLY TRP SER GLY LEU ILE GLU PHE SER GLY ARG SEQRES 14 B 210 GLN PHE VAL ASN ASP GLY GLN GLU LEU ILE TRP LYS THR SEQRES 15 B 210 LEU ARG ASN VAL GLY GLY LEU ALA THR GLY ALA VAL GLY SEQRES 16 B 210 ALA LEU GLY LEU ALA ALA LEU VAL GLY TYR ILE ALA ASN SEQRES 17 B 210 LYS ILE SEQRES 1 C 210 MET SER ASN THR ALA ASP PHE ARG LEU GLN THR SER THR SEQRES 2 C 210 LEU CYS HIS SER PHE LEU LEU ALA SER ALA ASN LYS GLN SEQRES 3 C 210 ASP THR ASP TYR LEU THR ASP LEU LEU ASP ASN THR ASN SEQRES 4 C 210 ILE ASP LEU THR CYS VAL PRO ASN GLY GLN GLU ILE ILE SEQRES 5 C 210 HIS SER LEU LEU GLN LEU VAL GLY ASP PHE ASN GLN ARG SEQRES 6 C 210 PHE SER GLN THR HIS GLU ILE GLU PRO VAL ALA GLN SER SEQRES 7 C 210 LEU GLY ILE ASP SER ASP LYS PRO VAL ASP LYS THR ALA SEQRES 8 C 210 LEU GLU ILE PHE TYR LEU GLU ILE LEU ASN GLY LEU PHE SEQRES 9 C 210 GLU LYS LEU ASN TRP GLY ARG ILE VAL ALA MET PHE ALA SEQRES 10 C 210 PHE LEU ARG ILE LEU VAL LEU ARG LEU SER LYS HIS GLY SEQRES 11 C 210 HIS SER ASP ALA ILE GLN MET LEU ILE LYS THR THR SER SEQRES 12 C 210 GLN TYR SER ASP GLU LYS LEU LYS ASN TRP ILE ASN LEU SEQRES 13 C 210 HIS ASP GLY TRP SER GLY LEU ILE GLU PHE SER GLY ARG SEQRES 14 C 210 GLN PHE VAL ASN ASP GLY GLN GLU LEU ILE TRP LYS THR SEQRES 15 C 210 LEU ARG ASN VAL GLY GLY LEU ALA THR GLY ALA VAL GLY SEQRES 16 C 210 ALA LEU GLY LEU ALA ALA LEU VAL GLY TYR ILE ALA ASN SEQRES 17 C 210 LYS ILE SEQRES 1 D 210 MET SER ASN THR ALA ASP PHE ARG LEU GLN THR SER THR SEQRES 2 D 210 LEU CYS HIS SER PHE LEU LEU ALA SER ALA ASN LYS GLN SEQRES 3 D 210 ASP THR ASP TYR LEU THR ASP LEU LEU ASP ASN THR ASN SEQRES 4 D 210 ILE ASP LEU THR CYS VAL PRO ASN GLY GLN GLU ILE ILE SEQRES 5 D 210 HIS SER LEU LEU GLN LEU VAL GLY ASP PHE ASN GLN ARG SEQRES 6 D 210 PHE SER GLN THR HIS GLU ILE GLU PRO VAL ALA GLN SER SEQRES 7 D 210 LEU GLY ILE ASP SER ASP LYS PRO VAL ASP LYS THR ALA SEQRES 8 D 210 LEU GLU ILE PHE TYR LEU GLU ILE LEU ASN GLY LEU PHE SEQRES 9 D 210 GLU LYS LEU ASN TRP GLY ARG ILE VAL ALA MET PHE ALA SEQRES 10 D 210 PHE LEU ARG ILE LEU VAL LEU ARG LEU SER LYS HIS GLY SEQRES 11 D 210 HIS SER ASP ALA ILE GLN MET LEU ILE LYS THR THR SER SEQRES 12 D 210 GLN TYR SER ASP GLU LYS LEU LYS ASN TRP ILE ASN LEU SEQRES 13 D 210 HIS ASP GLY TRP SER GLY LEU ILE GLU PHE SER GLY ARG SEQRES 14 D 210 GLN PHE VAL ASN ASP GLY GLN GLU LEU ILE TRP LYS THR SEQRES 15 D 210 LEU ARG ASN VAL GLY GLY LEU ALA THR GLY ALA VAL GLY SEQRES 16 D 210 ALA LEU GLY LEU ALA ALA LEU VAL GLY TYR ILE ALA ASN SEQRES 17 D 210 LYS ILE SEQRES 1 E 210 MET SER ASN THR ALA ASP PHE ARG LEU GLN THR SER THR SEQRES 2 E 210 LEU CYS HIS SER PHE LEU LEU ALA SER ALA ASN LYS GLN SEQRES 3 E 210 ASP THR ASP TYR LEU THR ASP LEU LEU ASP ASN THR ASN SEQRES 4 E 210 ILE ASP LEU THR CYS VAL PRO ASN GLY GLN GLU ILE ILE SEQRES 5 E 210 HIS SER LEU LEU GLN LEU VAL GLY ASP PHE ASN GLN ARG SEQRES 6 E 210 PHE SER GLN THR HIS GLU ILE GLU PRO VAL ALA GLN SER SEQRES 7 E 210 LEU GLY ILE ASP SER ASP LYS PRO VAL ASP LYS THR ALA SEQRES 8 E 210 LEU GLU ILE PHE TYR LEU GLU ILE LEU ASN GLY LEU PHE SEQRES 9 E 210 GLU LYS LEU ASN TRP GLY ARG ILE VAL ALA MET PHE ALA SEQRES 10 E 210 PHE LEU ARG ILE LEU VAL LEU ARG LEU SER LYS HIS GLY SEQRES 11 E 210 HIS SER ASP ALA ILE GLN MET LEU ILE LYS THR THR SER SEQRES 12 E 210 GLN TYR SER ASP GLU LYS LEU LYS ASN TRP ILE ASN LEU SEQRES 13 E 210 HIS ASP GLY TRP SER GLY LEU ILE GLU PHE SER GLY ARG SEQRES 14 E 210 GLN PHE VAL ASN ASP GLY GLN GLU LEU ILE TRP LYS THR SEQRES 15 E 210 LEU ARG ASN VAL GLY GLY LEU ALA THR GLY ALA VAL GLY SEQRES 16 E 210 ALA LEU GLY LEU ALA ALA LEU VAL GLY TYR ILE ALA ASN SEQRES 17 E 210 LYS ILE SEQRES 1 F 210 MET SER ASN THR ALA ASP PHE ARG LEU GLN THR SER THR SEQRES 2 F 210 LEU CYS HIS SER PHE LEU LEU ALA SER ALA ASN LYS GLN SEQRES 3 F 210 ASP THR ASP TYR LEU THR ASP LEU LEU ASP ASN THR ASN SEQRES 4 F 210 ILE ASP LEU THR CYS VAL PRO ASN GLY GLN GLU ILE ILE SEQRES 5 F 210 HIS SER LEU LEU GLN LEU VAL GLY ASP PHE ASN GLN ARG SEQRES 6 F 210 PHE SER GLN THR HIS GLU ILE GLU PRO VAL ALA GLN SER SEQRES 7 F 210 LEU GLY ILE ASP SER ASP LYS PRO VAL ASP LYS THR ALA SEQRES 8 F 210 LEU GLU ILE PHE TYR LEU GLU ILE LEU ASN GLY LEU PHE SEQRES 9 F 210 GLU LYS LEU ASN TRP GLY ARG ILE VAL ALA MET PHE ALA SEQRES 10 F 210 PHE LEU ARG ILE LEU VAL LEU ARG LEU SER LYS HIS GLY SEQRES 11 F 210 HIS SER ASP ALA ILE GLN MET LEU ILE LYS THR THR SER SEQRES 12 F 210 GLN TYR SER ASP GLU LYS LEU LYS ASN TRP ILE ASN LEU SEQRES 13 F 210 HIS ASP GLY TRP SER GLY LEU ILE GLU PHE SER GLY ARG SEQRES 14 F 210 GLN PHE VAL ASN ASP GLY GLN GLU LEU ILE TRP LYS THR SEQRES 15 F 210 LEU ARG ASN VAL GLY GLY LEU ALA THR GLY ALA VAL GLY SEQRES 16 F 210 ALA LEU GLY LEU ALA ALA LEU VAL GLY TYR ILE ALA ASN SEQRES 17 F 210 LYS ILE HET N3C A1001 102 HET N3C B1001 102 HET N3C C1001 102 HET N3C D1001 102 HET N3C E1001 102 HET N3C F1001 102 HETNAM N3C 4-{4-[(4'-CHLOROBIPHENYL-2-YL)METHYL]PIPERAZIN-1-YL}-N- HETNAM 2 N3C {[4-({(1R)-3-(DIMETHYLAMINO)-1-[(PHENYLTHIO) HETNAM 3 N3C METHYL]PROPYL}AMINO)-3-NITROPHENYL]SULFONYL}BENZAMIDE HETSYN N3C ABT-737 FORMUL 7 N3C 6(C42 H45 CL N6 O5 S2) FORMUL 13 HOH *32(H2 O) HELIX 1 AA1 ASP A 6 GLN A 26 1 21 HELIX 2 AA2 TYR A 30 LEU A 35 1 6 HELIX 3 AA3 ASP A 41 VAL A 45 5 5 HELIX 4 AA4 ASN A 47 PHE A 66 1 20 HELIX 5 AA5 PRO A 74 GLY A 80 1 7 HELIX 6 AA6 ASP A 88 PHE A 104 1 17 HELIX 7 AA7 ASN A 108 LYS A 128 1 21 HELIX 8 AA8 HIS A 131 LYS A 149 1 19 HELIX 9 AA9 LEU A 150 LEU A 156 1 7 HELIX 10 AB1 HIS A 157 SER A 161 5 5 HELIX 11 AB2 GLY A 162 GLY A 168 1 7 HELIX 12 AB3 ASP B 6 GLN B 26 1 21 HELIX 13 AB4 TYR B 30 LEU B 35 1 6 HELIX 14 AB5 ASP B 41 VAL B 45 5 5 HELIX 15 AB6 ASN B 47 PHE B 66 1 20 HELIX 16 AB7 ASP B 88 PHE B 104 1 17 HELIX 17 AB8 ASN B 108 LYS B 128 1 21 HELIX 18 AB9 HIS B 131 LYS B 149 1 19 HELIX 19 AC1 LEU B 150 LEU B 156 1 7 HELIX 20 AC2 SER B 161 SER B 167 1 7 HELIX 21 AC3 ASP C 6 LYS C 25 1 20 HELIX 22 AC4 TYR C 30 LEU C 35 1 6 HELIX 23 AC5 ASP C 41 VAL C 45 5 5 HELIX 24 AC6 ASN C 47 PHE C 66 1 20 HELIX 25 AC7 GLN C 68 GLY C 80 1 13 HELIX 26 AC8 ASP C 88 PHE C 104 1 17 HELIX 27 AC9 ASN C 108 LYS C 128 1 21 HELIX 28 AD1 HIS C 131 LEU C 150 1 20 HELIX 29 AD2 LEU C 150 LEU C 156 1 7 HELIX 30 AD3 GLY C 159 SER C 161 5 3 HELIX 31 AD4 GLY C 162 GLY C 168 1 7 HELIX 32 AD5 ASP D 6 GLN D 26 1 21 HELIX 33 AD6 TYR D 30 LEU D 35 1 6 HELIX 34 AD7 ASP D 41 VAL D 45 5 5 HELIX 35 AD8 ASN D 47 PHE D 66 1 20 HELIX 36 AD9 ASP D 88 PHE D 104 1 17 HELIX 37 AE1 ASN D 108 LYS D 128 1 21 HELIX 38 AE2 HIS D 131 LEU D 150 1 20 HELIX 39 AE3 LEU D 150 LEU D 156 1 7 HELIX 40 AE4 ASP D 158 TRP D 160 5 3 HELIX 41 AE5 SER D 161 GLY D 168 1 8 HELIX 42 AE6 ASP E 6 GLN E 26 1 21 HELIX 43 AE7 TYR E 30 LEU E 34 5 5 HELIX 44 AE8 ASP E 41 VAL E 45 5 5 HELIX 45 AE9 ASN E 47 PHE E 66 1 20 HELIX 46 AF1 PRO E 74 LEU E 79 1 6 HELIX 47 AF2 ASP E 88 PHE E 104 1 17 HELIX 48 AF3 ASN E 108 LYS E 128 1 21 HELIX 49 AF4 HIS E 131 LEU E 150 1 20 HELIX 50 AF5 LEU E 150 LEU E 156 1 7 HELIX 51 AF6 GLY E 159 GLY E 168 5 10 HELIX 52 AF7 ASP F 6 LYS F 25 1 20 HELIX 53 AF8 TYR F 30 LEU F 35 1 6 HELIX 54 AF9 ASP F 41 VAL F 45 5 5 HELIX 55 AG1 ASN F 47 PHE F 66 1 20 HELIX 56 AG2 PRO F 74 GLY F 80 1 7 HELIX 57 AG3 ASP F 88 PHE F 104 1 17 HELIX 58 AG4 ASN F 108 LYS F 128 1 21 HELIX 59 AG5 HIS F 131 LEU F 150 1 20 HELIX 60 AG6 LEU F 150 LEU F 156 1 7 HELIX 61 AG7 SER F 161 SER F 167 1 7 SITE 1 AC1 10 LEU A 58 PHE A 62 PHE A 66 LEU A 103 SITE 2 AC1 10 ASN A 108 GLY A 110 ARG A 111 ALA A 114 SITE 3 AC1 10 ILE A 121 PHE A 166 SITE 1 AC2 9 ASP B 61 PHE B 62 PHE B 66 ILE B 99 SITE 2 AC2 9 ASN B 108 ALA B 114 ALA B 117 PHE B 118 SITE 3 AC2 9 PHE B 166 SITE 1 AC3 11 LEU C 58 PHE C 62 PHE C 66 GLN C 68 SITE 2 AC3 11 LEU C 103 ASN C 108 GLY C 110 ALA C 114 SITE 3 AC3 11 PHE C 118 ILE C 121 PHE C 166 SITE 1 AC4 13 HIS C 70 GLU C 73 PRO C 74 LEU D 58 SITE 2 AC4 13 PHE D 62 PHE D 66 ILE D 99 LEU D 103 SITE 3 AC4 13 ASN D 108 GLY D 110 ARG D 111 ALA D 114 SITE 4 AC4 13 PHE D 166 SITE 1 AC5 10 LEU E 58 PHE E 62 ARG E 65 PHE E 66 SITE 2 AC5 10 ILE E 99 ASN E 108 GLY E 110 ARG E 111 SITE 3 AC5 10 ALA E 114 PHE E 166 SITE 1 AC6 13 ASP F 61 PHE F 62 ARG F 65 PHE F 66 SITE 2 AC6 13 ILE F 99 LEU F 103 ASN F 108 GLY F 110 SITE 3 AC6 13 ARG F 111 ALA F 114 PHE F 118 ILE F 121 SITE 4 AC6 13 PHE F 166 CRYST1 100.021 67.789 100.907 90.00 118.79 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009998 0.000000 0.005495 0.00000 SCALE2 0.000000 0.014752 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011308 0.00000